ROBERT HARDY: Open Payments
NPI 1982791729 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 14 payments from 8 companies in 2025. Trend: 2023 $397 · 2024 $314 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| ABBVIE INC. | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: ABILIFY MAINTENA, VRAYLAR, SPRAVATO, AUSTEDO XR, ABILIFY ASIMTUFII, Auvelity, HETLIOZ, UZEDY.
Industry payments across OH — which companies pay providers there.
